Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes

NCT03480945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2020-02-21

No results posted yet for this study

Summary

Study objective To evaluate the mechanism behind endothelial dysfunction in patients with type 2 diabetes in relation to the level of glycaemic control.

Primary endpoint: Change in endothelium dependent vasodilatation (EDV).

Conditions

Interventions

DIAGNOSTIC_TEST

serotonin

Endothelium-dependent dilatation

Sponsors & Collaborators

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-12-31
Completion
2019-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480945 on ClinicalTrials.gov